Myeloperoxidase (MPO) generates reactive halogenating species that can modify DNA. The aim of this study was to investigate the formation of 8-halogenated 2'-deoxyguanosines (8-halo-dGs) during inflammatory events. 8-bromo-2'-dG (8-BrdG) and 8-chloro-2'-dG (8-CldG) were generated by treatment of MPO with hydrogen peroxide at physiological concentrations of Cl -and Br -. The formation of 8-halo-dGs with other oxidative stress biomarkers in lipopolysaccharide (LPS)-treated rats was assessed by liquid chromatography tandem mass spectrometry (LC-MS/MS) and immunohistochemistry using a novel monoclonal antibody (mAb8B3) to 8-BrdG-conjugated keyhole limpet hemocyanin. The antibody recognized both 8-BrdG and 8-CldG. In the liver of LPS-treated rats, immunostaining for 8-halo-dGs, halogenated tyrosines, and MPO were increased at 8 h, while those of 8-oxo-2'-dG (8-OxodG) and 3-nitrotyrosine (3-NO 2 Tyr) were increased at 24 h. Urinary excretion of both 8-CldG and 8-BrdG was also observed earlier than those of 8-OxodG and modified tyrosines (3-NO 2 Tyr, 3-chlorotyrosine, and 3-bromotyrosine). Moreover, levels of the 8-halo-dGs in urine from human diabetic patients were 8X higher than in healthy subjects (N=10, healthy and diabetic, P<0.0001), while there was a moderate difference in 8-OxodG between the two groups (P<0.001). Interestingly, positive mAb8B3 antibody staining was observed in liver tissue from hepatocellular carcinoma patients, but not in liver tissue from human cirrhosis patients. These data suggest that 8-halo-dGs may be potential biomarkers of early inflammation.
Myeloperoxidase (MPO) generates reactive halogenating species that can modify DNA. The aim of this study was to investigate the formation of 8-halogenated 2'-deoxyguanosines (8-halo-dGs) during inflammatory events. OxodG  and  modified  tyrosines  (3-NO 2 Tyr,  3-chlorotyrosine,  and  3-bromotyrosine) . Moreover, levels of the 8-halo-dGs in urine from human diabetic patients were 8X higher than in healthy subjects (N=10, healthy and diabetic, P<0.0001), while there was a moderate difference in 8-OxodG between the two groups (P<0.001). Interestingly, positive mAb8B3 antibody staining was observed in liver tissue from hepatocellular carcinoma patients, but not in liver tissue from human cirrhosis patients. These data suggest that 8-halo-dGs may be potential biomarkers of early inflammation.
8-bromo-2'-dG (8-BrdG) and 8-chloro-2'-dG (8-
Oxidative damage is implicated in the pathogenesis of many diseases including atherosclerosis and cancer (1) (2) (3) (4) . Involvement of myeloperoxidase (MPO), a heme protein secreted by activated leukocytes such as neutrophils and monocytic cells, is a potential cause of oxidative damage during inflammation. At sites of inflammation, activated leukocytes play a major role in host defense against microorganisms using oxidants such as hypochlorous acid (HOCl) and hypobromous acid (HOBr). However, excessive oxidant release can also induce damage; DNA bases (5) (6) (7) (8) and proteins and lipids (9) (10) (11) (12) , for instance, are a putative target of oxidants.
At plasma halide concentrations (100 mM Cl -, 20-100 µM Br -) (13) , MPO converts HOCl to HOBr using Br -as a halide exchange (14) . HOBr is also generated by eosinophil peroxidase (EPO) using H 2 O 2 and Br -, such as by the MPO-H 2 O 2 -Cl -system. As MPO catalyzes halogenation, oxidation, and nitration (15) (16) (17) , MPO and its product may be important general markers for evaluating oxidative damage to the body during inflammation. Halogenation is a key reaction for the formation of an MPO-activity marker as the presence of halogen in the marker molecule directly indicates a contribution of the halogenating species at the site of oxidative damage. Moreover, no other halogenating pathways have been reported except for MPO and EPO-derived damage. Therefore, halogenated products have the potential to be specific markers of inflammation.
With respect to halogenation of nucleic acid, bromination of 2'-deoxycytidine (dC) and uracil has been reported in detail (18) (19) (20) . At physiological conditions, 5-bromo-dC was generated by human eosinophiles while 5-bromouracil was detected by GC/MS in the inflammatory tissue of human subjects suffering from a variety of bacterial infections (19, 20) . In human atherosclerotic tissue, 5-chlorouracil and 5-bromouracil were generated by MPO (3). An antibody against N 4 ,5-dichloro-deoxycytidine (N 4 ,5-diCldC) was developed and used for immunohistochemistry in lipopolysaccharide (LPS)-treated mice. In that inflammation model, immunopositive N 4 ,5-diCldC staining was observed in the liver (21) . Chlorination of deoxyguanosine (dG) by exposure to HOCl was also reported (22) . By contrast, there is little information on modification of dG by brominating species.
In the present study, we examined the patterns of brominated dG generation in vitro. We prepared the monoclonal antibody (mAb8B3) specific to 8-halogenated dGs (8-chloro-2'-deoxyguanosine (8-CldG) and 8-bromo-2'-deoxyguanosine (8-BrdG)). Using that antibody and LC-MS/MS, our results demonstrated facile formation of 8-halo-dGs in the liver and urine of rats administered LPS. Furthermore, with respect to the order of modification of dG, halogenation occurred prior to oxidation and nitration, which may be useful for evaluation of the progress of inflammatory diseases.
Experimental Procedures
Materials-2'-Deoxynucleosides, DNase I, nuclease P1, 8-oxo-2'-deoxyguanosine (8-OxodG), 3,3',5,5'-tetramethylbenzidine (TMB), bovine serum albumin (BSA), LPS from Escherichia coli, and 3,5-diaminobenzoic acid were obtained from Sigma-Aldrich. Methionine, taurine, 4-aminoantipyrine, sodium hypochlorite (NaOCl), metaphosphoric acid, and alkaline phosphatase were obtained from Wako Pure Chemicals Industries. Horseradish peroxidase-labeled goat anti-mouse IgG was obtained from Cappel. Anti-MPO polyclonal antibody was obtained from DAKO. HOBr was prepared from an equimolar solution of NaOCl and KBr as described (20) .
15 N 5 -dG was obtained from Spectra. Keyhole limpet hemocyanin (KLH) was obtained from Pierce.
Reaction conditions for dG modification by myeloperoxidase-As typical conditions, 1 mM dG, 20 nM MPO, 100 µM H 2 O 2 , 100 mM NaCl, and 100 µM NaBr were reacted for 60 min at 37°C in 50 mM phosphate buffer (pH 7.4). The reaction was terminated by adding catalase to scavenge H 2 O 2 . Each component was varied as described in the text. The formation of brominated dG was quantified by LC-MS/MS, as described below.
Preparation of , and 8-OxodG and their internal standards-Modified dGs and their stable isotopic internal standards were prepared as follows: (A) 8-CldG: dG (2 mM) was supplemented with nicotine (20 µM) in 50 mM phosphate buffer (pH 8.0). The reaction was initiated by adding NaOCl (1 mM) to the reaction mixture at 37°C for 1 h, and terminated by adding methionine (10 mM). (B) 8-BrdG: dG (2 mM) was supplemented with taurine (1 mM) in 50 mM phosphate buffer (pH 7.4). The reaction was initiated by adding HOBr (1 mM) to the reaction mixture at 37°C for 1 h, and terminated by adding methionine (10 mM). (C) 8-OxodG: dG (2 mM) was supplemented with ascorbate (1 mM) in 50 mM phosphate buffer (pH 7.4). The reaction was initiated by adding H 2 O 2 (1 mM) to the reaction mixture at 37°C for 4 h.
8-CldG, 8-BrdG, and 8-OxodG were isolated by reverse-phase HPLC (Develosil C30, 20 x 250 mm) using 10% acetonitrile containing 0.1% acetic acid at a flow rate of 6.0 ml/min with monitoring at 280 nm. The internal standards were prepared using 15 flow rate = 0.2 ml/min. The instrument response was optimized by infusion experiments of the standard compounds using a syringe pump at a flow rate of 5 µl/min. 8-halo-dGs were detected using electrospray ionization tandem mass spectrometry in the multiple reaction monitoring mode. Specific transitions used to detect products in the positive ionization mode were those between the molecular cation of the products and the characteristic daughter ion formed from the loss of the 2'-deoxyribose moiety. (B) 8-OxodG: The chromatographic separation was performed by a gradient elution as follows: 0-5 min, water containing 0.1% formic acid; 5-30 min, linear gradient to 50% acetonitrile containing 0.1% formic acid; 30-30.1 min, linear gradient to water containing 0.1% formic acid; 30.1-40 min, water containing 0.1% formic acid; flow rate = 0.2 ml/min. Optimization of the instrument response was performed as for 8-halo-dGs.
Preparation of the monoclonal antibody to 8-BrdG-To couple 8-BrdG to protein, the 5'-succinyl-8-BrdG derivative (suc-8-BrdG) was synthesized. Briefly, 8-BrdG (6.5 mg, 18.9 µmol) and succinic anhydride (3.8 mg, 37.8 µmol) were dissolved in pyridine (1 ml), and the mixture was kept at room temperature with stirring. After two days, the same amount of succinic anhydride was added and the mixture was kept overnight at room temperature. The solution was then evaporated and the residue was dissolved in methanol. Suc-8-BrdG was isolated by reverse-phase HPLC (Develosil C30, 8 x 250 mm) using 10% acetonitrile containing 0.1% acetic acid at a flow rate of 2.0 ml/min with monitoring at 280 nm. The obtained suc-8-BrdG (2.0 mg, yield 23.4%) was identified by 1 H-nuclear magnetic resonance (NMR) and LC/MS measurements (m/z 330, 332). The carboxyl group of the obtained suc-8-BrdG was conjugated to the amino group of KLH or BSA by the carbodiimide procedure as described previously (23) . The conjugate of suc-8-BrdG and KLH (8-BrdG-KLH) (0.6 mg/ml) was emulsified with an equal volume of complete Freund's adjuvant. Six-week-old female Balb/c mice were immunized with 100 µl of this emulsion intraperitoneally. After two weeks, the mice were boosted with the 8-BrdG-KLH (0.2 mg/ml) emulsified with an equal volume of incomplete Freund's adjuvant. In the final boost, 100 µl of the conjugate (0.5 mg/ml) in phosphate-buffered saline (PBS) was injected intravenously. Three days after the final boost, the mouse was killed and the spleen was removed for fusion with P3/U1 myeloma cells. The fusion was carried out by polyethylene glycol and the cells were cultured in hypoxanthine/aminopterin/thymidine selection medium. Five days after the fusion, culture supernatants of hybridomas obtained were screened by enzyme-linked immunosorbent assay (ELISA) using 8-BrdG-BSA and untreated BSA as the coating agents. The positive hybridomas against the 8-BrdG-BSA were cloned by the limiting dilution method. After repeated screening and cloning, four specific clones were obtained. Among them, a clone (termed mAb8B3) was used in the following experiments due to its specificity and high ability for cell growth.
ELISA-The indirect non-competitive ELISA procedure has been described previously (24) . Briefly, 100 µl of antigen in PBS was coated in wells and kept at 4°C overnight. After washing and blocking with 4% Block Ace (Dainihon Seiyaku), 100 µl of the mAb8B3 (1/2500 dilution) in PBS containing 0.05% Tween-20 (TPBS) was added and the wells were incubated at 37°C for 2 h. After washing, 100 µl of anti-mouse IgG goat peroxidase-labeled antibody (1/5000 in TPBS) was added and the wells incubated at 37°C for 1 h. After washing, 100 µl of reaction buffer (1% (w/v) 3,3',5,5'-tetramethylbenzidine (TMB) with 0.04% H 2 O 2 in 40 mM citrate-phosphate buffer, pH 5.0) was added. The color developing reaction was stopped by the addition of 100 µl of 1 N H 3 PO 4 . The binding of the antibody to the antigen was evaluated by measuring the optical density at 450 nm.
Competitive indirect ELISA was performed for estimating the cross-reactivity of the low molecular weight compounds with the antibody. The 8-BrdG-BSA conjugate (0.05 µg/well) was used as the coating antigen. For the competitive reaction, 50 µl of competitors in PBS were mixed with an equal volume of the antibody (1/2500 dilution) in PBS containing 4% BSA. The competitor solution was kept at 4°C overnight, and 90 µl of the mixture was used as the primary antibody. The cross-reactivity of the antibody to the competitors was expressed as B/B 0 , where B is the amount of mAb8B3 bound to the coating antigen in the presence of the competitor and B 0 in the absence of a competitor.
Animal experiments-Female Wistar rats (seven weeks old) were given an intraperitoneal injection of LPS from Escherichia coli (3 mg/kg body weight; Sigma) in PBS, or PBS alone. Rats were sacrificed at 2, 6, 12, 24, or 72 h after LPS/PBS and the livers immediately frozen until analysis. Rat urine was collected every 24 h from the day before LPS treatment to 10 days after administration. MPO -/-mice were developed and maintained as described previously (25) . Mice were given an intraperitoneal injection of LPS (1 mg/kg body weight) as described above. All sections were counterstained with hematoxylin.
Immunohistochemistry-Livers were collected, fixed with buffered formalin, and embedded in paraffin. In the case of livers from MPO -/-and control C57BL/6 mice, the specimens were fixed with Bouin's fluid. The 3 µm tissue sections were affixed to slides, the specimens deparaffinized, and antigen retrieval performed by microwave treatment in 0.01 M citrate buffer (pH 6.0) for 10 min. After cooling the slides at room temperature for 20 min, 1 N HCl was added for 30 min (for the primary antibody of modified DNA). The sections were blocked with normal rabbit serum (DAKO) in 1% BSA/PBS for 30 min and washed three times with PBS; normal swine serum (DAKO) was used for the anti-MPO antibody. The primary antibody (1/100 dilution) was reacted at 4°C overnight. After three PBS washes, biotinylated second anti-mouse IgG antibody (DAKO, 1/100 dilution) was reacted at room temperature for 40 min. Color development was achieved using the ABC-AP (alkaline phosphatase) kit (Vectastain) with a Vector Red commercial kit as the chromogen according to the manufacturer's recommendation. Specimens were finally counterstained with hematoxylin. Anti-3-nitrotyrosine (3-NO 2 Tyr) antibody was prepared as previously described (26) . Anti-thymine glycol (Tg) antibody and dihalotyrosine antibody (27) were obtained from Nikken Zeil Co. Human samples were obtained from surgical operations. The present study was approved by the Ethics Committee of Kyoto Prefectural University of Medicine.
Extraction of , and 8-OxodG from liver tissue-Liver tissue resected at surgery was immediately placed in liquid nitrogen and frozen at -80°C until analysis. The thawed tissue (100 mg wet weight) was homogenized at 4°C in 1 ml extraction buffer (10 mM methionine, 4 M urea, 0.2 M NaCl, 0.5% sodium N-lauroyl sarcosine, 10 mM ethylenediaminetetraacetic acid (EDTA), 10 mM Tris-HCl, pH 7.5). In brief, the homogenate was mixed with 20 µl of proteinase K (20 mg/ml) and kept at 55°C for 8 h. RNase (QIAGEN, 16 µl) was added and incubated for 2 min. After vortexing for 15 s, 1 ml of phenol was mixed and gently shaken for 30 min. The mixture was centrifuged for 10 min at 3,000 rpm at 4°C. DNA was collected with phenol and chloroform/isoamylalcohol mixture according to a conventional protocol. Prior to the enzymatic digestion of DNA, the buffer was supplemented with isotope-labeled internal . DNA was extracted as described (22, 28) .Enzymatic digestion of DNA with DNase I, nuclease P1, and alkaline phosphatase was performed as reported previously (29) . After digestion, the reaction mixtures were filtered through ultrafree-MC membrane (nominal molecular weight limit 5000; Millipore) by centrifugation (10,000 rpm, HIMAC centrifuge, Hitachi) to remove enzymes. 8-CldG, 8-BrdG, and 8-OxodG of the filtrates were fractionated by reversed-phase HPLC, and 10 µl of the samples was injected for LC-MS/MS as described above. MPO activity of rat liver tissue-Tissues were homogenized in 0.5% hexadecyltrimethyl-ammonium bromide/50 mM KH 2 PO 4 (pH 6), and centrifuged at 10,000 rpm at 4°C for 20 min. After 5 min, supernatant was added to the mixture of 150 µl of aqueous 2 mM H 2 O 2 and 130 µl of aqueous 25 mM 4-aminoantipyrine/1% phenol. The solution was then reacted for 5 min. The absorbance at 510 nm was measured (A 5 ). Instead of 2 mM H 2 O 2 /H 2 O, water was used as a standard (A 0 ). The MPO activity was assessed by subtracting A 0 from A 5 and normalized to the liver weight.
Measurement of TBARS in rat liver tissueThe lipid peroxidation levels were evaluated by measurement of the thiobarbituric acid-reactive substances (TBARS) as described previously (30) . In brief, each liver was homogenized in aqueous 1.15% KCl with 1% butylated hydroxytoluene (BHT). After centrifugation at 13,000 rpm at 4°C for 10 min, a portion of supernatant was diluted 50X with 1.15% KCl to measure the protein concentration. The supernatant (200 µl) was added to 225 µl of 20% acetic acid and 225 µl of 0.8% TBA, and further incubated at 100°C for 1 h. After cooling with water, the supernatant was centrifuged at 4,000 rpm at 4°C for 10 min, and the absorption was measured at 532 nm. TBARS data were normalized to the protein concentration.
GSH of rat liver tissue-
The liver was homogenized in 0.1 M phosphate buffer containing 5 mM EDTA and 1% BHT (pH 7.4). Homogenate was diluted 50X with buffer. A 100 µl volume of 25 mM metaphosphoric acid was added to the sample (400 µl) and was ultracentrifuged at 47,000 rpm at 4°C for 30 min. A 50 µl volume of supernatant was reacted with 50 µl of 1 mg/ml o-phthalaldehyde in 900 µl of buffer for 15 min. Fluorescence was measured at excitation 355 nm and emission 460 nm.
Creatinine assay-Urinary creatinine was determined by the Creatinine Test (WAKO) according to the manufacturer's recommendation. . After centrifugation at 12,000 rpm at 4°C for 10 min, the supernatant was diluted 10X with water and then fractionated. Partial fractionations of 8-modified dG were performed by reversed-phase HPLC as described above. Samples (10 µ l) were analyzed using LC-MS/MS as described above. Quantification of urinary modified tyrosines, 3-bromotyrosine (3-BrTyr), 3-chlorotyrosine (3-ClTyr), and 3-NO 2 Tyr, was performed as described previously (31) .
Analysis of urinary 8-modified dG and modified tyrosines using LC-MS/MS-
Statistics-Statistical significance of the intergroup differences of means for multiple groups were determined using the Student Newman-Keuls multiple comparisons test after one-way ANOVA to determine variations among the group means, followed by Bartlett's test to determine the homogeneity of variance. (Fig. 1A & 1B) . The formation of the collision-induced fragment ion (m/z 230 and 232) indicated the liberation of the deoxyribose moiety from the modified dG. The M+2 isotopic pattern strongly suggested the incorporation of a bromonium atom into dG ( 79 Br and 81 Br). Furthermore, this mass spectra pattern was consistent with 8-BrdG, the predominant reaction product from dG and HOBr. Therefore, the product was identified as 8-BrdG.
RESULTS

Reaction
The formation of 8-BrdG required MPO and H 2 O 2 , and was blocked by adding catalase, a scavenger of H 2 O 2 (Fig. 1C) . The reaction could not be completely prevented even in the absence of NaBr, likely because the NaCl in the buffer was contaminated with Br - (6) . The heme enzyme inhibitor, NaN 3 , inhibited the reaction. These results demonstrate that bromination of dG by MPO requires the active enzyme, Br -, and H 2 O 2 .
The effects of varying the reaction conditions on the generation of 8-BrdG and 8-CldG can be seen in Fig. 2 . As a basal condition, dG (1 mM) was incubated with 20 nM MPO, 100 µM H 2 O 2 , 100 mM NaCl, and 100 µM NaBr in 50 mM phosphate buffer (pH 7.4). Enzymatic bromination increased with H 2 O 2 concentration up to 300 µM. At 100 µM of Br -, which is the physiological concentration of Br -, the yield of 8-BrdG reached a plateau. Both halogenations were completed within 30 min, and the optimal pH for 8-BrdG generation was ~7. The production of 8-BrdG was decreased with increasing concentration of Cl -, suggesting a competitive reaction between Cl -and Br -with MPO.
Preparation and characterization of monoclonal antibody to 8-BrdG. We prepared a monoclonal antibody to 8-BrdG (mAb8B3) using 8-BrdG-conjugated KLH as an immunogen (Fig. 3) . Synthetic 8-BrdG was chemically modified for succinylation, and the succinyl moiety was then coupled to a carrier protein, KLH, as described previously (24) . Although the resulting antibody bound both 8-BrdG and 8-CldG, the reactivity against 8-BrdG was approximately 10X higher than for 8-CldG. The antibody showed little cross reactivity against 8-OxodG and 8-bromoguanosine (8-BrG), and could therefore distinguish the 8-substituted moiety of dG and deoxyribose. Thus, the antibody was considered to be an antibody to 8-halo-dGs.
Chlorination is considered a consequence of MPO, whereas bromination is related to both MPO and EPO. To confirm the availability of the antibody against MPO-derived halogenation in animals, we examined its immunoreactivity in the liver of LPS-treated wild type and MPO -/-mice. Following LPS-treatment, 8-halo-dGs immunoreactivity was observed in the liver of wild type mice but not MPO -/-mice (Fig. 4) , suggesting that the antibody can be used for estimation of MPO-derived modification. It is worthy to note that a weak signal in the cytoplasmic matrix was also observed.
Immunohistochemical detection of oxidative stress markers in the liver of LPS-treated rats. Immunostaining for oxidative stress markers, including the novel antibody to 8-halo-dGs, was examined in the liver of rats treated with LPS. The levels of MPO activity (i.e., a parameter of neutrophil infiltration) and TBARS (i.e., a parameter of lipid peroxidation) were significantly increased at 12 h after LPS treatment (Fig. 5A & 5B) . Moreover, a decrease of GSH (i.e., a parameter of reductant ability) was observed at 6 h after LPS treatment (Fig.  5C ). Immunopositive staining was observed in the livers of LPS-treated rats for all antibodies used, although the staining patterns varied between the antibodies (Fig. 6 ). An increase in 8-halo-dGs and MPO immunoreactivity in the liver of LPS-treated animals was observed at 6 and 12 h, respectively (Fig. 6A & 6B) . By contrast, oxidized and nitrated products, 8-OxodG and 3-NO 2 Tyr, exhibited immunoreactivity at 12 and 24 h after LPS. Although the antibody to 3-NO 2 Tyr was solely stained in the cytosol, both halo-dGs and 8-OxodG were stained in both the nuclei and a certain amount of the cytosol. A summary of the various immunostainings can be seen in Table 1 . (Table 1) . Thymine glycol (Tg) is a well-known oxidized dT, and the monoclonal antibody to Tg is commercially available.
The time-course of Tg immunostaining was similar to that of 8-OxodG (Table 1) . These data further suggest that halogenation of dG is an early and transient event in tissue inflammation.
Quantification of LPS-induced time-dependent generation of 8-CldG, 8-BrdG, and 8-OxodG in rat liver tissue by LC-MS/MS.
To further investigate the time-dependent generation of modified dG in the liver of LPS-treated rats, we analyzed 8-CldG, 8-BrdG, and 8-OxodG using LC-MS/MS with stable isotopic method (Fig. 7) . The LC-MS/MS method can simultaneously analyze 8-BrdG and 8-CldG, and also provides accurate quantitation with chemical identification. The pattern of changes obtained by LC-MS/MS was similar to that obtained by immunohistochemistry (Fig. 6) . The generation of 8-halo-dGs, 8-CldG and 8-BrdG began to increase between 2 and 6 h, peaked at 12 h, and then decreased to levels near that of control (0 h, PBS treatment only) at 24 h after LPS. By contrast, the level of 8-OxodG at 24 h remained higher than control levels, suggesting that 8-halo-dGs have different repair mechanisms than 8-OxodG.
Urinary 8-halo-dGs and 8-OxodG analysis in LPS-treated rats.
It was reported that 8-OxodG generated in DNA was excreted by human 8-oxoguanine DNA glycosylase (hOGG1) as a repair pathway (32) . The hOGG1 enzyme catalyzes expulsion of the 8-OxodG and cleavage of the DNA backbone. Similarly, 8-halo-dGs may also be excreted to urine by a repair enzyme. Urine from LPS-treated rat was collected every 24 h for 10 days. Samples containing 8-halo-dGs were partly purified by HPLC and then analyzed by LC-MS/MS. The LPS-induced change in 8-halo-dGs and 8-OxodG in the urine of rats can be seen in Fig.  8A -C. At one day after LPS treatment, elevated levels of 8-CldG and 8-BrdG were detected in urine, while 8-OxodG levels remained similar to controls. An increased excretion of 8-OxodG was observed at three days after LPS treatment. These data suggest that excretion of 8-halo-dGs into the urine in LPS-treated rats occurred earlier than for 8-OxodG.
Comparison with modified tyrosine markers in urine. 3-ClTyr, 3-BrTyr, and 3-NO 2 Tyr are used to evaluate oxidative modification, including MPO-derived protein modification in particular. Quantification of modified tyrosines in urine of LPS-treated rats over one week was performed by LC-MS/MS (Fig. 8D-F) . The levels of halogenated tyrosines were increased at two days and the levels of 3-NO 2 Tyr peaked at three days after LPS treatment. Thus, these modified tyrosines were excreted more slowly than for 8-halo-dGs.
Urinary 8-halo-dGs and 8-OxodG analysis in diabetic patients.
The basal level of 8-halo-dGs was analyzed in urine from healthy volunteers (N=10). The urine concentration of 8-halo-dGs (8-CldG and 8-BrdG) was 1.25 ± 0.65 and 1.38 ± 0.63 pmol/mg creatinine, respectively, while the concentration of 8-OxodG was 15.1 ± 5.71 pmol/mg creatinine. Diabetes is thought to be associated with oxidative stress as numerous studies show a relationship between oxidative stress markers and diabetes (31, 33) . In the present study, urinary 8-CldG and 8-BrdG levels from diabetic patients (N=10, 9.68 ± 2.64 and 10.0 ± 2.15 pmol/mg creatinine, respectively) were 8X higher than basal levels in healthy volunteers (P<0.0001), while there was a small increase in 8-OxodG in diabetic patients (22.9 ± 6.02 pmol/mg creatinine, P<0.001) (Fig. 9) .
8-halo-dGs immunostaining at an advanced stage of inflammation. As shown above, 8-halo-dGs seem to be an early marker of inflammation-derived oxidative tissue damage. We attempted to detect the 8-halo-dGs antigen in human hepatocellular carcinoma and cirrhosis, which may be models of advanced stage of inflammatory diseases. Interestingly, although no positive staining was observed in human cirrhosis, the nuclei and cytoplasmic matrix of cells from hepatocellular carcinoma showed significant 8-halo-dGs staining (Fig. 10) . (15), and tyrosine (16, 17) to generate HOBr, HOI, HOSCN, 3-NO 2 Tyr, and dityrosine, respectively, as intermediates and products. Furthermore, MPO acts as a major catalyst for initiation of lipid peroxidation (35) . Therefore, MPO catalyzes halogenation, nitration, and oxidation at sites of inflammation. However, a detailed mechanism for the formation of halogenated, nitrated, and oxidized products in vivo has not been fully established. DNA is considered an important target of modification due to the potential for inducing gene mutation, and various modifications of DNA bases by MPO-derived species have been described (18) (19) (20) (21) (22) . However, although chlorination of dG has been reported (22) , there are limited data on dG halogenation.
DISCUSSION
In the present study we estimated the modification of dG using the MPO-H 2 O 2 -Br -system, and formation of 8-BrdG was then confirmed by LC-MS/MS. A novel antibody to 8-BrdG (mAb8B3) was also prepared, which recognized both 8-BrdG and 8-CldG. In general, LC-MS/MS enables quantification of targets with high selectivity and sensitivity, while immunohistochemistry is useful for evaluating the presence and localization of target antigens in vivo. Thus, we assessed damage in LPS-treated rat using both LC-MS/MS and immunohistochemistry.
The antibody to 8-halo-dGs did not react with tissue derived from MPO -/-mice, suggesting that 8-halo-dGs were specifically generated by MPO (Fig. 4) . MPO catalyzed both 8-BrdG and 8-CldG formation reactions under physiological conditions (Fig. 2) . The immunoreactivity of the 8-halo-dGs antibody against pure 8-BrdG was much higher than against 8-CldG (Fig. 3) . However, because the concentration of 8-CldG in a biological sample was approximately 10X higher than that of 8-BrdG (Fig. 8) , it was difficult to estimate the contributions of the different 8-halo-dGs to the specimen staining.
LPS-induced liver damage occurred in the rats at 6 and 12 h after LPS treatment (Fig. 6) . A 300% increase in MPO activity and leukocyte infiltration was observed in LPS-treated animals compared with control animals. In support of these data, MPO-derived halogenated DNA bases,
8-halo-dGs and N 4 ,5-diCldC, dihalogenated tyrosine, and MPO were also detected by immunohistochemistry in the liver of rats at 6 and 12 h after LPS exposure (Fig. 6 and Table 1 ). Positive immunostaining for the oxidized DNA bases (8-OxodG and Tg) and the nitrated protein marker 3-NO 2 Tyr were observed at 12 and 24 h after LPS treatment. Furthermore, halogenation of dG occurred earlier than oxidation of dG (Fig. 8) . The LC-MS/MS results ( Fig.  7 ) suggest that 8-halo-dGs immunoreactivity (Fig. 6) should be due to expression of both 8-CldG and 8-BrdG. A compound which is rapidly and transiently formed during inflammation, like halo-dGs, should be suitable as an early oxidative stress bio-marker for monitoring complicated inflammation processes.
Some positive staining of 8-halo-dGs in the cytoplasmic matrix as well as the nuclei was observed (Fig. 4, 6, 10) . It is possible that the staining was due to a non-specific immunoreaction. Concerning the nitration of the nucleotide, the immunostaining of 8-nitroguanosine in the cytosol has been demonstrated (36, 37) . In these reports, the 8-nitroguanosine was localized mainly in the cytosol of virus-infected mouse lungs (36) and cultured cells (37) . The authors have suggested the nitroguanosine is stably formed in the nucleotide pool and RNA in the cytosol of the cells. This may apply to halogenation of DNA. Our antibody to 8-BrdG, which recognizes 8-CldG as well, hardly reacts with 8-bromoguanosine (Fig. 3B) , suggesting that the antibody detects neither halogenated RNA nor halogenated guanosine. 8-halo-dG moieties could be directly generated from free dG in the nucleotide pool. Weak immunoreactivity of 8-OxodG was found in cytoplasmic matrix (Fig. 4D ). It has been reported that 8-OxodG was accumulated in the cytoplasm as well as the nuclei in glioblastoma in some cases (38) . The nucleotide pool is considered to be an important target of 8-OxodG generation for oxidative stress (39) .
Urine 8-OxodG is generally used as a marker of oxidative stress. 8-OxodG is produced by reactive oxygen species under oxidative stress and excreted into the urine following recognition by the repair enzyme, 8-oxoguanine DNA glycosylase (hOGG1). The dedicated repair pathway for 8-OxoG was reported to involve hOGG1, an enzyme that recognizes oxoG-C base pairs and catalyzes exclusion of the 8-OxoG and cleavage of the DNA backbone (32) . The repaired 8-OxodG was shown to be excreted into urine, although there may be some further oxidation (40) . hOGG1 has also been shown to recognize the distortion of N-glycosyl bonds (41) . Furthermore, in organic chemistry, bromination of a base is usually employed to change an N-glycosyl bond from anti to syn, while the stability of an oligonucleoside containing 8-BrdG is lower than that of dG (42) . In the present study, although urine 8-halo-dGs levels increased rapidly following LPS, there was a slower rise in 8-OxodG (Fig. 8) . Thus, the early increase in urine 8-halo-dGs in LPS-treated rats may also reflect the fact that 8-halo-dGs are easily catalyzed by DNA repair enzymes, such as hOGG1.
Interestingly, the levels of 8-halo-dGs were significantly elevated in urine of diabetic patients (Fig. 9) , a disease considered to be associated with oxidative stress and inflammation (33) . It was previously shown that 8-OxodG levels in the urine was affected by age, gender, and degree of disease (43) . In the present study, urine 8-halo-dGs were not affected by gender in either healthy or diabetic patients (data not shown); however, as yet we have not assessed enough samples, and a more detailed study is required. There was significant staining of hepatocellular carcinoma cells with the anti-8-halo-dGs antibody (Fig. 10) . This may relate to active gene transcription or replication processes, which increase the chance of mutation by reactive species or incorporation of a pooled modified dG. Conversely, there was no anti-8-halo-dGs immunostaining in liver tissue from cirrhosis patients. The detection of MPO and HOCl-modified protein in the human liver, including those with cirrhosis, has been reported (44) , although decreased production of reactive oxygen species by neutrophils in patients with liver cirrhosis was also demonstrated (45) . This reduction in reactive oxygen species may cause a reduced halogenating ability in the cirrhotic liver, as MPO requires hydrogen peroxide as a substrate to catalyze the production of halogenating species. In addition, we have found that 8-BrdG was effectively generated by bromamines rather than HOBr itself in vitro (unpublished results). Thus, intracellular amines including nucleotides could act as halogenating species (as a carrier) in vivo.
In summary, we successively quantified the halogenated, oxidized, and nitrated products in the liver and urine of rats treated with LPS, and suggest that halogenation might occur earlier than nitration and oxidation in this model. The levels of urinary 8-halo-dGs were relatively low compared with 8-OxodG, but still detectable even in control subjects. Furthermore, the levels of urinary 8-halo-dGs in diabetic patients were higher than in control subjects. These data suggest that leukocyte-derived halogenated products such as 8-halo-dGs have potential as novel and early biomarkers of oxidative stress for assessment of inflammatory damage.
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